Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs Warfarin in Nonvalvular Atrial Fibrillation (ARISTOTLE)
NCT00412984Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2006
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 41
01
Overview
A Phase 3 trial of apixaban in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Bristol Myers Squibb. Started Dec 2006; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT00412984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00412984.